Viking Therapeutics (VKTX) Operating Income (2014 - 2026)
Viking Therapeutics' (VKTX) quarterly Operating Income came in at -$132.6 million in Q2 2026, down 77.81% year-over-year from -$597.4 million in Q2 2025, and up 19.21% quarter-over-quarter from -$164.1 million in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) Operating Income (2014 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Operating Income across 13 years of filings, most recently posting -$132.6 million for Q2 2026.
- In Q2 2026, Operating Income fell 77.81% year-over-year to -$132.6 million; the TTM figure through Jun 2026 stood at -$560.0 million (down 163.12% YoY), while the FY2025 annual figure was -$393.3 million, down 160.63% from the prior year.
- Operating Income came in at -$132.6 million for Q2 2026 at Viking Therapeutics, up from -$164.1 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$16.2 million in Q3 2022 to a low of -$164.7 million in Q4 2025.
- Average Operating Income over 5 years is -$56.2 million, with a median of -$34.1 million recorded in 2024.
- Year-over-year, Operating Income slipped 13.45% in 2022 and slumped 256.28% in 2025.
- Over 5 years, Operating Income stood at -$20.3 million in 2022, then sank by 44.38% to -$29.3 million in 2023, then slumped by 57.89% to -$46.2 million in 2024, then tumbled by 256.28% to -$164.7 million in 2025, then increased by 19.51% to -$132.6 million in 2026.
- Per Business Quant data, the three most recent Operating Income figures were -$132.6 million in Q2 2026, -$164.1 million in Q1 2026, and -$164.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | -132.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -132.60 Mn |
| Mar 31, 2026 | -164.13 Mn |
| Dec 31, 2025 | -164.74 Mn |
| Sep 30, 2025 | -98.56 Mn |
| Jun 30, 2025 | -74.57 Mn |
| Mar 31, 2025 | -55.47 Mn |
| Dec 31, 2024 | -46.24 Mn |
| Sep 30, 2024 | -36.56 Mn |
| Jun 30, 2024 | -34.05 Mn |
| Mar 31, 2024 | -34.07 Mn |
| Dec 31, 2023 | -29.29 Mn |
| Sep 30, 2023 | -27.27 Mn |
| Jun 30, 2023 | -23.74 Mn |
| Mar 31, 2023 | -20.54 Mn |
| Dec 31, 2022 | -20.28 Mn |
| Sep 30, 2022 | -16.20 Mn |
| Jun 30, 2022 | -17.63 Mn |
| Mar 31, 2022 | -16.25 Mn |
| Dec 31, 2021 | -12.51 Mn |
| Sep 30, 2021 | -13.40 Mn |
API Access
Viking Therapeutics Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();